Managing  	Managing  	 VBG	B-NP
hyponatremia  	hyponatremia  	 NN	I-NP
in  	in  	 IN	O
cirrhosis  	cirrhosis  	 VBG	O
The  	The  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
hyponatremia  	hyponatremia  	 NN	B-NP
represents  	represents  	 VBZ	O
an  	an  	 DT	O
ominous  	ominous  	 JJ	B-NP
event  	event  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
progression  	progression  	 NN	O
of  	of  	 IN	O
cirrhosis  	cirrhosis  	 VBG	O
to  	to  	 TO	O
end-stage  	end-stage  	 JJ	B-NP
liver  	liver  	 NN	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
usually  	usually  	 RB	O
develops  	develops  	 VBZ	O
in  	in  	 IN	O
those  	those  	 DT	O
with  	with  	 IN	O
refractory  	refractory  	 JJ	B-NP
ascites  	ascites  	 NN	I-NP
and  	and  	 CC	O
is  	is  	 VBZ	O
a  	a  	 DT	O
manifestation  	manifestation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
non-osmotic  	non-osmotic  	 JJ	I-NP
release  	release  	 NN	I-NP
of  	of  	 IN	I-NP
arginine  	arginine  	 JJ	I-NP
vasopressin  	vasopressin  	 NNS	I-NP
( 	( 	 -LRB-	O
AVP 	AVP 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
hospitalized  	hospitalized  	 JJ	O
cirrhotic  	cirrhotic  	 JJ	B-NP
patient 	patient 	 NN	I-NP
,  	,  	 ,	O
hyponatremia  	hyponatremia  	 NN	B-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
disease  	disease  	 NN	B-NP
severity  	severity  	 NN	I-NP
and  	and  	 CC	O
mortality 	mortality 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
article 	article 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
review  	review  	 VB	O
the  	the  	 DT	O
pathophysiology  	pathophysiology  	 NN	B-NP
of  	of  	 IN	I-NP
hyponatremia 	hyponatremia 	 NN	I-NP
,  	,  	 ,	O
its  	its  	 PRP$	O
clinical  	clinical  	 JJ	B-NP
implications 	implications 	 NNS	I-NP
,  	,  	 ,	O
evaluation 	evaluation 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
